Phase 2 Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with moderate-to-severe atopic dermatitis (eczema)
- People whose eczema did not respond well enough to, or who could not tolerate, at least one topical (applied to the skin) treatment before the screening visit, or for whom topical treatments are considered unsuitable
- Female participants who are not currently pregnant or breastfeeding, and who are either not able to become pregnant, or who agree to use a highly effective form of contraception during the trial
- Male participants who agree to use a highly effective form of contraception during the trial
- People whose eczema severity scores meet specific thresholds measured by the trial team, including an EASI score of 16 or higher and a vIGA-AD score of 3 or higher (the trial site will assess these)
- People where eczema covers at least 10% of their body surface area
- People who have experienced significant itch on most days in the week before joining the trial, based on a rating scale score of 4 or higher
Who may not be able to join:
- People who test positive for hepatitis B, hepatitis C, or HIV
- People who show signs of active or latent (inactive but present) tuberculosis (TB)
- People with a history of TB that was never treated or was not adequately treated
- People who currently have an active infection requiring systemic (whole-body) treatment such as antibiotics, antivirals, or antifungal medicines
- People who have another unstable, itchy skin condition alongside their eczema that could make it difficult for the trial team to accurately assess the eczema
- People with other health conditions or abnormal test results that the trial doctor believes could increase health risks during the study or make it harder to interpret the results
- People who have recently received certain specific treatments within defined timeframes before starting the trial (confirm with trial site for the full list of affected treatments and timeframes)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (858) 345-6927
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mean percent change from baseline in EASI at Week 24
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.